Kevin M. O's most recent trade in Phillips 66 was a trade of 949 Common Stock done at an average price of $172.8 . Disclosure was reported to the exchange on March 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Phillips 66 | Kevin O. Meyers | Director | Grant, award, or other acquisition of securities at price $ 172.84 per share. | 16 Mar 2026 | 949 | 16,449 (0%) | 0% | 172.8 | 164,023 | Common Stock |
| Phillips 66 | Kevin O. Meyers | Director | Purchase of securities on an exchange or from another person at price $ 173.20 per share. | 16 Mar 2026 | 175 | 16,624 (0%) | 0% | 173.2 | 30,310 | Common Stock |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.97 per share. | 01 Feb 2026 | 462 | 22,518 | - | 79.0 | 36,484 | Common Stock, par value $0.01 per share |
| Hershey | Kevin M. Ozan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2026 | 246 | 1,848 (0%) | 0% | 0 | Common Stock | |
| Twin Disc Incorporated | Kevin M. Olsen | Director | Grant, award, or other acquisition of securities at price $ 14.88 per share. | 30 Oct 2025 | 5,378 | 26,066 (0%) | 0% | 14.9 | 79,998 | COMMON STOCK |
| Hershey | Kevin M. Ozan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 225 | 1,590 (0%) | 0% | 0 | Common Stock | |
| McKesson | Kevin M. Ozan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2025 | 301 | 301 | - | - | Restricted Stock Units (RSUs) | |
| Hershey | Kevin M. Ozan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 241 | 1,355 (0%) | 0% | 0 | Common Stock | |
| Hershey | Kevin M. Ozan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 250 | 1,104 (0%) | 0% | 0 | Common Stock | |
| Hess | Kevin O. Meyers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 1,395 | 38,597 (0%) | 0% | 0 | Common Stock, $1.00 par value | |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 130.25 per share. | 04 Mar 2025 | 2,724 | 75,446 (0%) | 0% | 130.3 | 354,801 | Common Stock |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2025 | 14,291 | 78,170 (0%) | 0% | 0 | Common Stock | |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.46 per share. | 02 Mar 2025 | 1,567 | 63,879 (0%) | 0% | 131.5 | 205,998 | Common Stock |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 13,231 | 13,231 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 4,626 | 22,980 | - | 0 | Common Stock, par value $0.01 per share | |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.35 per share. | 01 Mar 2025 | 2,140 | 19,875 | - | 87.4 | 186,929 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.35 per share. | 01 Mar 2025 | 1,521 | 18,354 | - | 87.3 | 132,859 | Common Stock, par value $0.01 per share |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 12,654 | 70,961 (0%) | 0% | 0 | Common Stock | |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 126.49 per share. | 20 Feb 2025 | 5,155 | 65,446 (0%) | 0% | 126.5 | 652,056 | Common Stock |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.30 per share. | 01 Feb 2025 | 462 | 22,015 | - | 88.3 | 40,795 | Common Stock, par value $0.01 per share |
| Hershey | Kevin M. Ozan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 251 | 847 (0%) | 0% | 0 | Common Stock | |
| Twin Disc Incorporated | Kevin M. Olsen | Director | Grant, award, or other acquisition of securities at price $ 11.86 per share. | 31 Oct 2024 | 6,747 | 20,688 (0%) | 0% | 11.9 | 79,999 | COMMON STOCK |
| Hershey | Kevin M. Ozan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 221 | 591 (0%) | 0% | 0 | Common Stock | |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.44 per share. | 03 Aug 2024 | 1,533 | 22,477 | - | 83.4 | 127,914 | Common Stock, par value $0.01 per share |
| McKesson | Kevin M. Ozan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2024 | 349 | 349 | - | - | Restricted Stock Units (RSUs) | |
| Hershey | Kevin M. Ozan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 367 | 367 (0%) | 0% | 0 | Common Stock | |
| Hess | Kevin O. Meyers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 1,398 | 37,202 (0%) | 0% | 0 | Common Stock, $1.00 par value | |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.01 per share. | 06 Mar 2024 | 884 | 58,017 (0%) | 0% | 91.0 | 80,453 | Common Stock |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2024 | 18,790 | 58,901 (0%) | 0% | 0 | Common Stock | |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.22 per share. | 02 Mar 2024 | 1,922 | 40,111 (0%) | 0% | 93.2 | 179,169 | Common Stock |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 9,202 | 9,202 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 3,235 | 24,010 | - | 0 | Common Stock, par value $0.01 per share | |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.28 per share. | 01 Mar 2024 | 3,059 | 20,775 | - | 91.3 | 279,226 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.28 per share. | 01 Mar 2024 | 2,140 | 25,551 | - | 91.3 | 195,339 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.28 per share. | 01 Mar 2024 | 1,717 | 23,834 | - | 91.3 | 156,728 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.28 per share. | 01 Mar 2024 | 1,309 | 27,691 | - | 91.3 | 119,486 | Common Stock, par value $0.01 per share |
| McKesson | Ozan Kevin M. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 225 | 225 | - | - | Restricted Stock Units (RSUs) | |
| Denbury Inc Ordinary Shares | Kevin O. Meyers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.41 per share. | 07 Aug 2023 | 748 | 52,418 (0%) | 0% | 35.4 | 26,487 | Common Stock |
| Denbury Inc Ordinary Shares | Kevin O. Meyers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2023 | 748 | 0 | - | - | Series B Warrants (Right to Buy) | |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.19 per share. | 03 Aug 2023 | 1,532 | 22,493 | - | 76.2 | 116,723 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2023 | 13,275 | 0 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.40 per share. | 31 Jul 2023 | 13,275 | 37,300 | - | 40.4 | 536,310 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Sale of securities on an exchange or to another person at price $ 77.46 per share. | 31 Jul 2023 | 13,275 | 24,025 | - | 77.5 | 1,028,282 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Sale of securities on an exchange or to another person at price $ 76.55 per share. | 31 Jul 2023 | 2,334 | 24,025 | - | 76.6 | 178,668 | Common Stock, par value $0.01 per share |
| Dime Community Bancshares Inc | Kevin M. O'Connor | Director, Director and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 9,852 | 269,345 (0%) | 0% | 0 | Common Stock | |
| Dime Community Bancshares Inc | Kevin M. O'Connor | Director, Director and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.72 per share. | 31 Mar 2023 | 1,152 | 259,493 (0%) | 0% | 22.7 | 26,173 | Common Stock |
| Denbury Inc Ordinary Shares | Kevin O. Meyers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2023 | 2,652 | 51,670 (0%) | 0% | 0 | Common Stock | |
| Hess | Kevin O. Meyers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 1,413 | 35,804 (0%) | 0% | 0 | Common Stock, $1.00 par value | |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.88 per share. | 06 Mar 2023 | 1,034 | 41,720 (0%) | 0% | 84.9 | 87,766 | Common Stock |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 16,662 | 16,662 | - | - | Employee Stock Option (right to buy) | |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 6,573 | 42,754 (0%) | 0% | 0 | Common Stock | |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.28 per share. | 02 Mar 2023 | 1,206 | 36,181 (0%) | 0% | 91.3 | 110,084 | Common Stock |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 10,188 | 10,188 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 3,652 | 28,431 | - | 0 | Common Stock, par value $0.01 per share | |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.30 per share. | 01 Mar 2023 | 1,309 | 27,122 | - | 75.3 | 98,568 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.04 per share. | 01 Mar 2023 | 763 | 26,359 | - | 75.0 | 57,256 | Common Stock, par value $0.01 per share |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 5,587 | 39,817 (0%) | 0% | 0 | Common Stock | |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.38 per share. | 22 Feb 2023 | 2,430 | 37,387 (0%) | 0% | 93.4 | 226,913 | Common Stock |
| McDonald's | Kevin M. Ozan | SEVP - Strategic Initiatives | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2023 | 11,980 | 0 | - | - | Restricted Stock Units | |
| McDonald's | Kevin M. Ozan | SEVP - Strategic Initiatives | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2023 | 11,980 | 33,948 (0%) | 0% | 0 | Common Stock | |
| McDonald's | Kevin M. Ozan | SEVP - Strategic Initiatives | Payment of exercise price or tax liability using portion of securities received from the company at price $ 269.99 per share. | 18 Feb 2023 | 5,143 | 29,688 (0%) | 0% | 270.0 | 1,388,559 | Common Stock |
| McDonald's | Kevin M. Ozan | SEVP - Strategic Initiatives | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2023 | 883 | 34,831 (0%) | 0% | 0 | Common Stock | |
| McDonald's | Kevin M. Ozan | SEVP - Strategic Initiatives | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2023 | 883 | 0 | - | - | Dividend Equivalent Rights | |
| Dime Community Bancshares Inc | Kevin M. O'Connor | Director, Director and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.57 per share. | 15 Feb 2023 | 1,560 | 260,645 (0%) | 0% | 31.6 | 49,249 | Common Stock |
| McDonald's | Kevin M. Ozan | SEVP - Strategic Initiatives | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 5,069 | 12,863 | - | - | Restricted Stock Units | |
| GE HealthCare Tech | M. O’Neill Kevin | CEO, PDx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 6,507 | 29,000 | - | 0 | Common Stock, par value $0.01 per share | |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 1,347 | 0 | - | - | Employee Stock Option (right to buy) | |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.55 per share. | 03 Feb 2023 | 1,347 | 35,209 (0%) | 0% | 72.6 | 97,725 | Common Stock |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 99.87 per share. | 03 Feb 2023 | 979 | 34,230 (0%) | 0% | 99.9 | 97,773 | Common Stock |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 17,244 | 17,244 | - | - | Employee Stock Option (right to buy) | |
| Dime Community Bancshares Inc | Kevin M. O'Connor | Director, Director and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.60 per share. | 01 Feb 2023 | 5,523 | 262,205 (0%) | 0% | 30.6 | 169,004 | Common Stock |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 1,964 | 24,779 | - | 0 | Common Stock, par value $0.01 per share | |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.55 per share. | 31 Jan 2023 | 3,909 | 37,248 (0%) | 0% | 72.6 | 283,598 | Common Stock |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 3,909 | 1,347 | - | - | Employee Stock Option (right to buy) | |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.06 per share. | 31 Jan 2023 | 3,386 | 33,862 (0%) | 0% | 97.1 | 328,645 | Common Stock |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 13,275 | 13,275 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 10,820 | 10,820 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 9,106 | 9,106 | - | - | Restricted Stock Units | |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 6,519 | 6,519 | - | - | Restricted Stock Units | |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 5,877 | 5,877 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 5,568 | 5,568 | - | - | Restricted Stock Units | |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 5,051 | 5,051 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 4,592 | 4,592 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 3,672 | 3,672 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 3,329 | 3,329 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 3,106 | 3,106 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 1,653 | 1,653 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 1,622 | 1,622 | - | - | Restricted Stock Units | |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 1,614 | 1,614 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 343 | 343 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | Kevin M. O’Neill | CEO, PDx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 59 | 59 | - | - | Common stock, par value $0.01 per share | |
| Twin Disc Incorporated | Kevin M. Olsen | Director | Grant, award, or other acquisition of securities at price $ 11.25 per share. | 27 Oct 2022 | 6,443 | 8,544 (0%) | 0% | 11.3 | 72,503 | COMMON STOCK |
| Twin Disc Incorporated | Kevin M. Olsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2022 | 2,101 | 2,101 (0%) | 0% | 0 | COMMON STOCK | |
| Dime Community Bancshares Inc | Kevin M. O'Connor | Director, Director and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 6,768 | 267,728 (0%) | 0% | 0 | Common Stock | |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2022 | 7,114 | 37,242 (0%) | 0% | 0 | Common Stock | |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.52 per share. | 06 Mar 2022 | 4,127 | 33,115 (0%) | 0% | 96.5 | 398,338 | Common Stock |
| Hess | Kevin O. Meyers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2022 | 1,730 | 34,391 (0%) | 0% | 0 | Common Stock, $1.00 par value | |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 13,910 | 13,910 | - | - | Employee Stock Option (right to buy) | |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 4,669 | 30,128 (0%) | 0% | 0 | Common Stock | |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.36 per share. | 02 Mar 2022 | 698 | 25,459 (0%) | 0% | 96.4 | 67,259 | Common Stock |
| McDonald's | Kevin M. Ozan | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 51,045 | 51,045 | - | - | Options (Right to Buy) |